Product Information
IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1676 per EA under NDC 00093823898. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
12.5; 150 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093823898
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA077369On Market Since
1/24/2013
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1676 per EA |
|---|---|
| All-time high | $0.3512 (May 14, 2014) |
| All-time low | $0.1308 (Jul 17, 2024) |
| 52-week high | $0.1696 |
| 52-week low | $0.1533 |
| Median price | $0.2461 |
| Average price | $0.2403 |
| Largest weekly change | +39.6% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1676 per EA (NDC 00093823898), effective Jun 24, 2026.
How has the price of IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB changed over time?
Over the history we have for it, the NADAC for IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB has declined 48.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB?
Since Nov 28, 2013, the NADAC for IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB has ranged from a low of $0.1308 (Jul 17, 2024) to a high of $0.3512 (May 14, 2014), with a median of $0.2461 per EA.
Are there cheaper alternatives to IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB, is $0.1405 per EA — about 16% below IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB.
Who manufactures IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB?
IRBESARTAN-HYDROCHLOROTHIAZIDE 150-12.5 MG TB (NDC 00093823898) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification